Page last updated: 2024-12-06

benzo(a)pyrene 7,8-oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

benzo(a)pyrene 7,8-oxide: RN given refers to cpd without isomeric designation; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37455
CHEBI ID34563
SCHEMBL ID16744739
MeSH IDM0080615

Synonyms (21)

Synonym
6-beta,7-alpha-dihydrobenzo(10,11)chryseno(1,2-b)oxirene
benzo(a)pyrene 7,8-oxide
bp 7,8-oxide
benzo(10,11)chryseno(1,2-b)oxirene, 6-beta,7-alpha-dihydro-
benzo(a)pyrene, 7,8-dihydro-7,8-epoxy-
benzo(a)pyrene-7,8-epoxide
bp 7,8-epoxide
7,8-epoxy-7,8-dihydrobenzo(a)pyrene
benzo(a)pyrene 7,8-epoxide
benzo[a]pyrene-7,8-epoxide
benzo[a]pyrene-7,8-oxide
36504-65-1
SCHEMBL16744739
CHEBI:34563
OLLMQFHYRYHKTD-UHFFFAOYSA-N
Q27116152
7,8-dihydro-7,8-epoxybenzo[a]pyrene
DTXSID80957806
6b,7a-dihydrobenzo[1,12]tetrapheno[8,9-b]oxirene
6b,7a-dihydrobenzo[12,1]tetrapheno[8,9-b]oxirene
6-oxahexacyclo[11.6.2.02,8.05,7.010,20.017,21]henicosa-1(20),2(8),3,9,11,13(21),14,16,18-nonaene
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pyrenes
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (72.73)18.7374
1990's2 (18.18)18.2507
2000's1 (9.09)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.59 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.07 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other11 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]